ShareValue.ai

ShareValue scores for 600613.SHG: Valuation 59, Quality 34, Growth 30, Health 62.

600613.SHG
SSE

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

CN¥4.61(+3.13%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 16%
Valuation
59
Fair Value
Price vs Value
Quality
34
Weak
Business Strength
Growth
30
Weak
Revenue & Earnings
Health
62
Moderate
Financial Stability
Momentum
35
Bearish
Price Trend

Company Details

About

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin injection, loquat cough granules, strong loquat dew, loquat cough capsules, jinwu gutong capsules, coral ringworm net, jingwu capsules, quantianma capsules, yindan xintai pills, etc. The company was founded in 1990 and is based in Shanghai, China.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026